부산대학교 도서관

Van, Wigcheren GF; De, Haas N; Mulder, TA; Horrevorts, SK; Bloemendal, M; Hins-Debree, S; Mao, Y; Kiessling, R; van, Herpen CML; Florez-Grau, G

ONCOIMMUNOLOGY. 10(1)

Driessen, CML; Groenewoud, JMM; de Boer, JP; Gelderblom, H; van der Graaf, WTA; Prins, JB; Kaanders, JHAM; van Herpen, CML

Support Care Cancer
Supportive Care in Cancer, 26, 4, pp. 1233-1242

Boon, E; van Boxtel, W; Buter, J; Baatenburg de Jong, RJ; van Es, RJJ; Bel, M; Fiets, E; Oosting, SF; Slingerland, M; Hoeben, A; Tesselaar, MET; Jonker, MA; Flucke, UE; Nationwide Network and Registry of Histopathology and Cytopathology (PALGA) Group; van der Graaf, WTA; van Herpen, CML

Head Neck
Boon, E, van Boxtel, W, Buter, J, Baatenburg de Jong, R J, van Es, R J J, Bel, M, Fiets, E, Oosting, S F, Slingerland, M, Hoeben, A, Tesselaar, M E T, Jonker, M A, Flucke, U E, van der Graaf, W T A & van Herpen, C M L 2018, 'Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma : A nationwide case series of 35 patients in The Netherlands', Head and Neck, vol. 40, no. 3, pp. 605-613. https://doi.org/10.1002/hed.25035
Head and Neck : Journal for the Sciences and Specialties of the Head and Neck, 40, 3, pp. 605-613

van Ruitenbeek NJ; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.; Uijen MJM; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.; Driessen CML; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.; van Rijk MC; Department of Medical Imaging, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Peters SMB; Department of Medical Imaging, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Privé BM; Department of Medical Imaging, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Verhaegh GW; Department of Urology, Radboud Institute for Molecular Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; van Engen-van Grunsven ACH; Department of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Gotthardt M; Department of Medical Imaging, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Nagarajah J; Department of Medical Imaging, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Roentgeninstitut Duesseldorf, Duesseldorf, Germany.; van Herpen CML; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands. Carla.vanHerpen@radboudumc.nl.

Publisher: Springer Berlin Country of Publication: Germany NLM ID: 101560946 Publication Model: Electronic Cited Medium: Print ISSN: 2191-219X (Print) Linking ISSN: 2191219X NLM ISO Abbreviation: EJNMMI Res Subsets: PubMed not MEDLINE

van Ravensteijn SG; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Amir AL; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Tauriello DVF; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Wesseling YJW; InnoSIGN B.V. High Tech Campus 11, Eindhoven, the Netherlands.; van Brussel AGC; InnoSIGN B.V. High Tech Campus 11, Eindhoven, the Netherlands.; Keizer DM; InnoSIGN B.V. High Tech Campus 11, Eindhoven, the Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE

Weijers JAM; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, Nijmegen, 6525 GA, The Netherlands.; Verhaegh GW; Department of Urology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA, Nijmegen, The Netherlands.; Lassche G; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, Nijmegen, 6525 GA, The Netherlands.; van Engen-van Grunsven ACH; Department of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA, Nijmegen, The Netherlands.; Driessen CML; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, Nijmegen, 6525 GA, The Netherlands.; van Erp NP; Department of Pharmacy, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA, Nijmegen, The Netherlands.; Jonker MA; Science Department IQ Health, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA, Nijmegen, The Netherlands.; Schalken JA; Department of Urology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA, Nijmegen, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, Nijmegen, 6525 GA, The Netherlands. Carla.vanHerpen@radboudumc.nl.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

van Ravensteijn SG; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Nederkoorn MJL; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Hillebrandt-Roeffen MHS; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Gorris MAJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; de Bitter TJJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Boleij A; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Gusinac A; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Ederveen THA; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Flucke UE; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.; Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Smits M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

van Ruitenbeek NJ; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Uijen MJM; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Driessen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Peters SMB; Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Privé BM; Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; van Engen-van Grunsven ACH; Department of Pathology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Konijnenberg MW; Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.; Gotthardt M; Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Nagarajah J; Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Roentgeninstitut Duesseldorf, Duesseldorf, Germany.; van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

Palazzo, Antonella; Iacovelli, Roberto; Cortesi, Enrico

Acta Oncologica (ACTA ONCOL), Aug2013; 52(6): 1235-1235. (1p)

Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA.; Loriot Y; DITEP, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Necchi A; Department of Medical Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy.; Singh P; Department of Oncology, Mayo Clinic, Phoenix, AZ.; Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain.; Pagliaro L; Department of Oncology, Mayo Clinic, Rochester, MN.; Suarez C; Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; McGregor BA; Dana-Farber Cancer Institute, Boston, MA.; Vaishampayan UN; University of Michigan, Ann Arbor, MI.; Hauke RJ; Nebraska Cancer Specialists-Midwest Cancer Center, Omaha, NE.; Powles T; Barts Health NHS Trust Saint Bartholomew's Hospital, London, United Kingdom.; Van Herpen CML; Radboud Universitair Medisch Centrum, Nijmegen, the Netherlands.; Courtney KD; University of Texas Southwestern Medical Center, Dallas, TX.; Dreicer R; University of Virginia Cancer Center, Charlottesville, VA.; Sudhagoni R; Exelixis, Inc, Alameda, CA.; Schwickart M; Exelixis, Inc, Alameda, CA.; Andrianova S; Exelixis, Inc, Alameda, CA.; Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

de Heus E; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van de Camp K; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; Driehuis E; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; van der Zwan JM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Merkx MAW; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.; Duijts SFA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; Department of Medical Psychology, Amsterdam University Medical Centers, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.

Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1611 (Electronic) Linking ISSN: 10579249 NLM ISO Abbreviation: Psychooncology Subsets: MEDLINE

Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Looze EJ; Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Thavaneswaran S; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van Berge Henegouwen JM; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van der Wijngaart H; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Sebastian L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Lin FP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Thomas DM; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Clinical Oncology, LUMC, Leiden, the Netherlands.; Head of Melanoma Clinic, CHUV, Lausanne, Switzerland.; van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.; Eskens FALM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Jalving M; Department of Medical Oncology, University of Medical Center Groningen, Groningen, the Netherlands.; Gietema JA; Department of Medical Oncology, University of Medical Center Groningen, Groningen, the Netherlands.; Devriese LA; Department of Medical Oncology, Division Beeld & Oncologie, Utrecht University Medical Center, Utrecht, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, Location VUMC, Cancer Center Amsterdam, the Netherlands.; Barjesteh van Waalwijk van Doorn-Khosrovani S; CZ Health Insurance, Tilburg, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.; Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

de Heus E; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, the Netherlands; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Duijts SFA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, the Netherlands; Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer treatment and Quality of life, Amsterdam, the Netherlands. Electronic address: s.duijts@iknl.nl.; van der Zwan JM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, the Netherlands; Department of Healthcare Transformation, SeederDeBoer, Amsterdam, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Merkx MAW; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, the Netherlands; IQ healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.; Rutherford MJ; Biostatistics Research Group, Department of Population Health Sciences, George Davies Centre, University of Leicester, Leicester, UK; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.; Soerjomataram I; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101508793 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-783X (Electronic) Linking ISSN: 18777821 NLM ISO Abbreviation: Cancer Epidemiol Subsets: MEDLINE

Resteghini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Baujat B; Department of Otorhinolaryngology Head and Neck Surgery, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris, France.; Bossi P; Department of Biomedical Sciences, Humanitas University, Milan, Italy; Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.; Franchi A; Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; de Gabory L; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Bordeaux, Bordeaux, France.; Halamkova J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czechia; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czechia.; Haubner F; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Munich, LMU Klinikum, Munich, Germany.; Hardillo JAU; Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Hermsen MA; Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Iacovelli NA; Radiation Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Maroldi R; Division of Radiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.; Mattheis S; Clinic for Ear, Nose and Throat Medicine, Head and Neck Surgery, University Hospital Essen, Essen, Germany.; Moya-Plana A; Department of Head and Neck Surgery, Gustave Roussy Cancer Campus-Paris Saclay University, Villejuif, France.; Nicolai P; Otolaryngology Unit, University of Padova, Padua, Italy.; Orlandi E; Department of Clinical-Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.; Thariat J; Department of Radiation Oncology, Centre François Baclesse, Caen, France; Laboratoire de physique Corpusculaire IN2P3/ENSICAEN/CNRS UMR 6534-Normandie Université, Caen, France.; Trama A; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; van den Brekel MWM; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Amsterdam Center for Language and Communication, University of Amsterdam, Amsterdam, The Netherlands; Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Verillaud B; Department of Head and Neck Surgery, Lariboisière Hospital, Université Paris Cité, Paris, France.; Kinloch E; Salivary Gland Cancer UK, London, UK.; Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Even C; Department of Head and Neck Cancer, Gustave Roussy Cancer Campus, Villejuif, France.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: In Process; MEDLINE

Bol KF; Medical Oncology, Radboudumc, Nijmegen, Netherlands.; Peeters E; Medical Imaging, Radboudumc, Nijmegen, Netherlands.; van Herpen CML; Medical Oncology, Radboudumc, Nijmegen, Netherlands.; Westdorp H; Medical Oncology, Radboudumc, Nijmegen, Netherlands.; Aarntzen EHJG; Medical Imaging, Radboudumc, Nijmegen, Netherlands.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Devriese LA; Division Beeld & Oncologie, Department of Medical Oncology, Utrecht University Medical Center, Utrecht, the Netherlands.; Erdkamp FLG; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geleen, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands.; Bins AD; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Notohardjo JCL; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Geurts BS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Leek LVM; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; Hoes LR; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van de Haar J; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Ommen-Nijhof A; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kok M; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Hoeben A; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.; Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

de Bitter TJJ; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands. Tessa.JJ.deBitter@radboudumc.nl.; de Reuver PR; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Surgery, Nijmegen, The Netherlands.; de Savornin Lohman EAJ; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Surgery, Nijmegen, The Netherlands.; Kroeze LI; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.; Vink-Börger ME; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.; van Vliet S; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.; Simmer F; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.; von Rhein D; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Human Genetics, Nijmegen, The Netherlands.; Jansen EAM; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Human Genetics, Nijmegen, The Netherlands.; Verheij J; Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam, The Netherlands.; van Herpen CML; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, The Netherlands.; Nagtegaal ID; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.; Ligtenberg MJL; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Human Genetics, Nijmegen, The Netherlands.; van der Post RS; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Pathology, Nijmegen, The Netherlands.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Verhoeff SR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Aarntzen EHJG; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Miedema IHC; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Voortman J; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Menke-van der Houven van Oordt WC; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Boellaard R; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Vriens D; Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Hermsen R; Department of Nuclear Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands; and.; Grunsven IVE; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Heskamp S; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Carla.vanherpen@radboudumc.nl.

Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE